FDA Approved: BENICAR — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for BENICAR (olmesartan medoxomil) filed by Cosette Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• BENICAR (OLMESARTAN MEDOXOMIL)

Snippet

SUPPL AP for BENICAR (OLMESARTAN MEDOXOMIL)